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Soon after the introduction of the one- and two-
stage methods for determining prothrombin, it was
noted that while the results obtained by the two
procedures generally agreed fairly well, marked
discrepancies occurred in certain specific instances.
Particularly puzzling has been the observation
that the prothrombic activity of human blood
as compared with dog blood, when measured by the
two tests, is markedly different. Warner, Brink-
hous and Smith (1) reported that the prothrombin
concentration in dog blood is 350 units per cc. and
in human blood 295 units. More recently Murphy
and Seegers (2) found 190 to 205 units in dog and
290 to 315 in human blood. Mann and his as-
sociates (3, 4) reported that the average for dog
blood is 183 units per cc. and for human blood 319
units. These findings indicate that the prothrom-
bin concentration as measured by the two-stage
method is approximately the same in the two spe-
cies. When determined by the one-stage method,
the prothrombic activity of dog blood, in marked
contrast, is many-fold higher than in human blood
(5). The reason for this divergency has not been
satisfactorily explained, but obviously as long as
this problem remains unsolved, a marked gap in
the knowledge concerning prothrombin remains.
In the present investigation human and dog bloods
were studied by means of the prothrombin con-
sumption test and by the adsorption and elution
technique for determining prothrombin with the
aim of obtaining new data that might be helpful in
arriving at a better understanding of what consti-
tutes prothrombic activity.
METHODS
The prothrombin consumption time. The directions as
previously outlined were followed (6, 7). In carrying
out the prothrombin consumption test on serum from
1 This work was supported by a grant from the Division
of Research Grants and Fellowships of the National In-
stitutes of Health, U. S. Public Health Service.
platelet-poor plasma, blood is collected with a silicone-
coated needle and syringe, and immediately transferred to
silicone-coated test tubes immersed in an ice bath. After
the tubes are chilled for 10 minutes, they are centrifuged
in an Angle Centrifuge at 8000 r.p.m. for 10 minutes.
One cc. of the plasma (having a platelet count less than
3000 per mm.) is transferred to a glass test tube and
placed in a water bath at 370 C. The fibrin is removed
as it forms by wrapping it about a glass stirring rod.
When the coagulation of fibrinogen is complete, the se-
rum is tested every five minutes for its prothrombic ac-
tivity. Usually it becomes constant in 15 minutes. The
prothrombin time is determined as follows: To a mixture
consisting of 0.1 cc. deprothrombinized oxalated rabbit
plasma, 0.1 cc. thromboplastin and 0.1 cc. 0.02 M CaCl2
solution, 0.1 cc. of serum is added by blowing from a
pipette. The formation of the clot is accurately timed.
The determination of prothrombin by the adsorption
and elution technique as developed by Stefanini and the
writer (8) was followed. In this test the prothrombin is
adsorbed with tricalcium phosphate and then eluted with
sodium citrate. Since one volume of eluate contains the
prothrombin of 10 volumes of plasma, the eluate is mixed
with nine volumes of deprothrombinized rabbit plasma for
assaying its prothrombic activity. Rabbit plasma has
been found to be a satisfactory assay medium because it
has a high and constant concentration of labile factor.
RESULTS
A comparative study of the prothrombic ac-
tivity of human and dog plasmas and sera are re-
corded in Table I. The prothrombin time of nor-
mal human plasma is 12 seconds and of dog plasma
six seconds. The same values are obtained when
determined by the adsorption and elution pro-
cedure. On storing oxalated human and dog
plasma in an open container at 40 C., the pro-
thrombin time steadily increases but in human
plasma the rise is much more rapid. If depro-
thrombinized rabbit plasma, which is a rich source
of labile factor, is added to the stored human
plasma, the prothrombin time is decreased to eight
seconds. Likewise, the eluate obtained from aged
human plasma yields a prothrombin time of eight
seconds. When the labile factor is restored in
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TABLE I
The comparative prothrombic activity of dog and
human plasma and serum
Experi-
ment
no.
Proth
Direct
(sec.)
1. Dog plasma fresh 6
2. Dog plasma fresh, 9 volumes +
Rabbit Ca3(PO4)2 plasma, 1 volume 6
3. Dog plasma stored 2 days 8
4. Dog plasma stored, 9 volumes +
Rabbit Ca3(PO4)2 plasma,* 1 volume 6
5. Dog serum from platelet-rich plasma 15
6. Dog serum from platelet-poor plasma 63
7. Normal human plasma fresh 12
8. Normal human plasma fresh,
9 volumes + Rabbit Ca3(PO4)2
plasma, 1 volume 1219. Normal human plasma stored 2 days 17
10. Normal human plasma stored,
9 volumes + Rabbit Ca3(PO4)2
plasma, 1 volume 8
11. Normal human serum from
platelet-rich plasma 21
12. Normal human serum from
platelet-poor plasma 8
rombin time
t Of eluate
(sec.)
6
6
6
15
61
12
* Fresh oxalated rabbit plasma treated with Ca3(PO4)2.
stored dog plasma, the prothrombin time again
becomes six seconds; likewise the eluate has this
value. There is, however, no increase in pro-
thrombic activity during storage.
When platelet-rich human or dog plasma is
clotted, the serum has a comparatively marked de-
crease in prothrombic activity. If the plasma is
clotted after the removal of platelets, human se-
rum has a prothrombin time of about eight seconds
while dog serum has a value of six and one-half
seconds. Native plasma, either platelet-rich or
poor, from a severe hemophiliac, when clotted in
glass yields a serum that has a prothrombin time of
eight to eight and one-half seconds. In every in-
stance the direct prothrombin time agrees with that
obtained by the adsorption and elution procedure.
DISCUSSION
The simplest explanation for the difference of
the prothrombin times of dog and human plasmas
is that the former contains a much higher concen-
tration of prothrombin than does human plasma.
This conclusion is supported by the finding that
on assaying the eluates of dog and human plasmas,
it is found that their prothrombin times are six
and 12 seconds respectively-the same as found
by the direct one-stage test.
Although it has been shown that increasing
the labile factor above the minimum level required
for optimum prothrombin time does not further
shorten it (9), it may still be claimed that the
higher concentration of labile factor in dog blood
might be responsible for the faster clotting time.
When the prothrombin is determined by the ad-
sorption and elution procedure, the labile factor
is not a variable, because in the assay of the eluate,
a standard amount of deprothrombinized rabbit
plasma, which has a high concentration of labile
factor, is employed. The close agreement between
the results of the direct one-stage and the adsorp-
tion and elution method is good evidence that the
labile factor does not influence the results of the
one-stage method unless it is below the minimal
requirement.
When normal dog blood clots, the prothrombin
time of the serum increases because most of the
prothrombin is converted to thrombin. In the ex-
periment recorded in Table I, Exp. 5, the pro-
thrombin time of the serum is 15 seconds. By
means of the prothrombin curve for dog blood ob-
tained by saline as a diluent (7), one can estimate
that over 90 per cent of the prothrombin in this
serum is consumed. In marked contrast, when
platelet-poor plasma clots, the prothrombin time
of the serum is practically the same as that of the
plasma (Table I, Exp. 6). On account of the
lack of platelets, so little thromboplastin apparently
becomes available that only a very small amount
of prothrombin is consumed. It is to be noted that
in serum from both platelet-rich and poor plasma
the prothrombin time by the direct one-stage
method agrees with the values obtained by the
adsorption and elution test. When oxalated dog
plasma is stored, the prothrombin time slowly in-
creases, but the eluate from this aged plasma had
a prothrombin time of six to six and one-half sec-
onds (Table I, Exp. 3) which clearly shows that
no significant change in prothrombin occurs in
dog plasma during short periods of storage.
When normal human blood clots, the serum has
a prothrombin time which usually ranges from 15
to 30 seconds. This illustrates that, as in dog
blood, much of the prothrombin is consumed dur-
ing clotting. Fresh native plasma depleted of
platelets by high centrifugation when clotted in
glass yields a serum which has a prothrombin time
of about eight seconds (Table I, Exp. 12). Sig-
nificantly, the serum obtained from the clotting of
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TABLE II
The changes in prothrombic activity observed
blood on storage and after clotti,
Experi-
ment
no.
pi
D
1. Hemophilic plasma fresh* 1
2. Hemophilic plasma stored 2 days 1
3. Hemophilic plasma stored,
9 volumes + Rabbit Ca3(PO4)2,
1 volume
4. Hemophilic serum from platelet-
rich plasma
5. Hemophilic serum from platelet-
poor plasma
* From a severe hemophiliac.
plasma of a severe hemophilic subject
a prothrombin time of eight seconds e
platelets are not diminished (Table II
5). Furthermore, both normal an
blood when stored 24 to 48 hours hav
bin time of approximately eight secor
marked and relatively fixed increase
bic activity occurs in sera from platele
plasma, from hemophilic blood or pl
stored normal and hemophilic blood.
these sera or plasmas is more than
quantity of prothrombin consume
nearly all of the prothrombin remains
ever, does not account for the strikir
prothrombic activity. The most dir
plest explanation is that an actual inc
thrombin occurs. For this to hapl
postulate that plasma contains an
precursor form of prothrombin.
developed the hypothesis that all
(serozyme) in circulating blood is i
form. Quick and Stefanini (9) cc
in human plasma part of the prothror
but a much greater proportion is in
state. This inactive prothrombin, lil
thrombin, is completely adsorbed and
eluate in contact with glass likew
markedly in prothrombic activity, pr
cause the precursor is gradually cb
tive prothrombin. Recently it was f
quantity of thromboplastin requiredI
prothrombic activity varies with the
concentration (11). When the pr
reduced by means of Dicumarol or v
ficiency, the thromboplastin requirem
Considerably more thromboplastin is
tain the minimum prothrombin tiI
plasma than of fresh plasma, which suggests that
d in hemophilic an increase of prothrombin itself occurs.
ng If the increase in prothrombic activity is not
Irothrombin time)irect Of eluate due to an increase of active prothrombin, then
'sec.) (e.sec.) s c.) it becomes necessary to postulate that an accelera-[2 12[8 8 tor is generated to account for the decrease of the
prothrombin time from the normal of 12 seconds to
8 eight seconds. Alexander and his associates (12)
8-9 8-9 have attempted to establish that such a specific
8 8 agent exists. They have named it spca (serumprothrombin converting accelerator) because they
maintain that the prothrombic activity of serum
t likewise has is due largely to the evolution of this factor dur-
ven when the ing clotting. If their contentions are correct, then
Exps. 4 and the marked increase of prothrombic activity found
d hemophilic in the serum from hemophilic or from thrombo-
ea prothrom- cytopenic blood should be due to spca, but ac-
nds. Thus, a cording to their findings this factor is low in these
in prothrom- sera (13, 14). From this it would follow that the
t-free normal marked hyperprothrombic activity in these sera
asmas and in is not due to the evolution of an accelerator but
In none of to an actual increase in prothrombin.
a very small According to Alexander, spca, like prothrombin,
d; therefore, is adsorbed by BaSO4 and eluted with sodium ci-
;. This, how- trate. In isolating spca, they allow blood to clot
ig increase in and treat the serum with BaSO4 (20 mgm. per 1 cc.
rect and sim- serum). From their statement (15): "most of the
crease in pro- prothrombic activity was in the supernatant" after
pen one may adsorption with BaSO4, one must infer that these
inactive or investigators assume that differential adsorption
Bordet (10) occurs in which spca is separated from prothrom-
prothrombin bin. On repeating their procedure, it has been
in an inactive found that as much as two-thirds of the prothrom-
)ncluded that bic activity of serum is removed by 20 mgm. of
nbin is active, BaSO4 per 1 cc. (16). There is therefore a strong
the precursor probability that the separation of spca and pro-
ke active pro- thrombin is more apparent than real and that the
I eluted. The product considered to be the accelerator contains
rise increases an undetermined amount of prothrombin. Alex-
resumably be- ander and Landwehr's (17) finding that the evolu-
ianged to ac- tion of spca during storage is small in various hy-
ound that the poprothrombic states might well be explained by
for maximum a low concentration of prothrombin in the acceler-
prothrombin ator preparation. To determine how much of the
*othrombin is activity is due to prothrombin and how much to
ritamin K de- an accelerator becomes not only a formidable but
lent decreases. a speculative problem.
needed to ob- Thus, while the possibility of an accelerator
me of stored factor should not be ignored, it seems simpler and
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perhaps more firmly supported by experimental
evidence that the hyperprothrombic activity in the
conditions discussed is due to an actual increase
in active prothrombin. The statement of Stefanini
and Crosby (18) that the prothrombin time of se-
rum is not influenced by the activation of the pre-
cursor of prothrombin in less than two hours after
the completion of clotting is not in accord with
the findings of the writers. In the clotting of na-
tive human plasma the prothrombin time of the
serum attains a constant value in about 15 minutes
after all the fibrinogen has been converted to fibrin.
In oxalated plasma, the conversion of inactive
prothrombin to the active state is slow. At 40 C.
the reaction usually requires more than 24 hours
to go to completion, even in contact with a glass
surface, and in a silicone-coated container it even
takes considerably longer. This permits the re-
moval of both prothrombin and prothrombinogen
from oxalated plasma by adsorption with trical-
cium phosphate, and the subsequent recovery of
both forms by elution with sodium citrate.
The finding that neither storage nor the clotting
of platelet-poor dog plasma causes an increase of
prothrombic activity such as is observed in human
plasma, makes it unlikely that dog blood contains
a prothrombin converting factor of the type of
spca. One is at a loss, therefore, to find a better
explanation for the high prothrombic activity of
dog blood than that it contains a much higher con-
centration of active prothrombin than does human
blood, but has little or no inactive prothrombin.
SUMMARY
The comparative prothrombic activity of dog
and human blood were studied by means of the
one-stage prothrombin test, the prothrombin con-
sumption test and the adsorption and elution tech-
nique for determining prothrombin.
It was found that the prothrombic activity of
dog blood is much greater than that of human
blood. When oxalated dog plasma is stored, the
prothrombin time is increased due to loss of labile
factor. When the latter is restored, the prothrom-
bin time returns to the value obtained for fresh
plasma. The serum from platelet-poor normal
plasma has a prothrombin time only slightly less
than that of plasma.
Human plasma on storage likewise shows a pro-
gressive decrease of prothrombic activity but when
the labile factor is restored, the prothrombin time
becomes shorter than that of the fresh plasma. A
similar increase in prothrombic activity is found
when normal platelet-poor plasma, or hemophilic
plasma clots.
Possible explanations for these findings are
discussed. It is concluded that dog blood con-
tains a high concentrate of free or active prothrom-
bin but little or no inactive prothrombin, whereas
human plasma has a much smaller amount of
free prothrombin, but a high concentration of in-
active prothrombin (prothrombinogen), which in
contact with a glass surface becomes converted to
the active state.
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